前のページに戻るこの文献は全文を取り寄せることができます

JDreamⅢ複写サービスから文献全文の複写（冊子体のコピー）をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。

既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方

JDreamⅢ複写サービス
文献複写のお申込み

JDreamⅢ複写サービスのご利用が初めての方

学術文献の全文複写をお取寄せ
JDreamⅢ複写サービスのご案内

取り寄せる文献のタイトルと詳細

文献

J-GLOBAL ID：202202216195624978 整理番号：22A0859670

分子腫瘍ボードポータルは精密腫瘍学のための臨床決定と自動報告を支持する【JST・京大機械翻訳】

The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology

著者 (37件)：

Tamborero David

(Department of Oncology and Pathology, Karolinska Institutet, Science for Life Laboratory, Stockholm, Sweden)

,

Dienstmann Rodrigo

(Medical Oncology, Oncology Data Science, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain)

,

Rachid Maan Haj

(Department of Oncology and Pathology, Karolinska Institutet, Science for Life Laboratory, Stockholm, Sweden)

,

Boekel Jorrit

(Department of Oncology and Pathology, Karolinska Institutet, Science for Life Laboratory, Stockholm, Sweden)

,

Lopez-Fernandez Adria

(Hereditary Cancer Genetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain)

,

Jonsson Markus

(Department of Oncology and Pathology, Karolinska Institutet, Science for Life Laboratory, Stockholm, Sweden)

,

Razzak Ali

(Department of Oncology and Pathology, Karolinska Institutet, Science for Life Laboratory, Stockholm, Sweden)

,

Brana Irene

(Medical Oncology Department, Vall d’Hebron University Hospital, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain)

,

De Petris Luigi

(Department of Oncology and Pathology, Karolinska Institutet, Theme Cancer, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden)

,

Yachnin Jeffrey

(Department of Oncology and Pathology, Karolinska Institutet, Theme Cancer, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden)

,

Baird Richard D.

(Cancer Research UK Cambridge Centre, Cambridge, UK)

,

Loriot Yohann

(Departement d’Innovation Therapeutique et d’Essais Precoces, Gustave Roussy, Universite Paris-Saclay, Villejuif, France)

,

Massard Christophe

(Departement d’Innovation Therapeutique et d’Essais Precoces, Gustave Roussy, Universite Paris-Saclay, Villejuif, France)

,

Martin-Romano Patricia

(Departement d’Innovation Therapeutique et d’Essais Precoces, Gustave Roussy, Universite Paris-Saclay, Villejuif, France)

,

Opdam Frans

(The Netherlands Cancer Institute, Amsterdam, the Netherlands)

,

Schlenk Richard F.

(NCT Trial Center, German Cancer Research Center, Heidelberg University Hospital, Heidelberg, Germany)

,

Vernieri Claudio

(Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy)

,

Vernieri Claudio

(IFOM, FIRC Institute of Molecular Oncology, Milan, Italy)

,

Masucci Michele

(Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden)

,

Villalobos Xenia

(Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain)

,

Chavarria Elena

(Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain)

,

Cancer Core Europe consortium

,

Balmana Judith

(Hereditary Cancer Genetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain)

,

Apolone Giovanni

(Scientific Directorate, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy)

,

Caldas Carlos

(Cancer Research UK Cambridge Centre, Cambridge, UK)

,

Bergh Jonas

(Department of Oncology and Pathology, Karolinska Institutet, Theme Cancer, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden)

,

Ernberg Ingemar

(Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden)

,

Frohling Stefan

(National Center for Tumor Diseases Heidelberg, German Cancer Research Center, Heidelberg, Germany)

,

Garralda Elena

(Medical Oncology Department, Vall d’Hebron University Hospital, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain)

,

Karlsson Claes

(Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden)

,

Karlsson Claes

(Department of Hematology, Karolinska University Hospital, Stockholm, Sweden)

,

Tabernero Josep

(Medical Oncology Department, Vall d’Hebron University Hospital, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain)

,

Voest Emile

(The Netherlands Cancer Institute, Amsterdam, the Netherlands)

,

Voest Emile

(Oncode Institute, Utrecht, the Netherlands)

,

Rodon Jordi

(Medical Oncology Department, Vall d’Hebron University Hospital, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain)

,

Rodon Jordi

(Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA)

,

Lehtio Janne

(Clinical Proteomics Unit, Department of Oncology and Pathology, Karolinska Institutet, Science for Life Laboratory, Karolinska University Hospital, Stockholm, Sweden)

資料名：

Nature Cancer (Nature Cancer)

巻： 3 号： 2 ページ： 251-261 発行年： 2022年
JST資料番号： W6368A ISSN： 2662-1347 資料種別：逐次刊行物 (A)
記事区分：原著論文発行国：ドイツ (DEU) 言語：英語 (EN)

JDreamⅢ複写サービスとは

JDreamⅢ複写サービスは、学術文献の全文を複写（コピー）して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写（コピー）は郵送またはFAXでお送りします

※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。

TOP

BOTTOM